• Vacancies
  • Researcher for the Access to Medicine Index
Vacancy Access to Medicine Index - closing on 13 May 2019

Researcher for the Access to Medicine Index

The Access to Medicine Foundation is now strengthening its research capacity. We are looking for a talented researcher motivated to guide pharmaceutical companies to do more for the two billion people in the world without access to the medicines they need. 


1 year (with possibility of renewal).


At least 3 years.


2,600 EUR - 3,300 EUR per month gross.


Amsterdam, the Netherlands.

Closing date:

Applications will be reviewed on a rolling basis.

Start date:

As soon as possible.

The Access to Medicine Foundation is a non-profit organisation based in Amsterdam, the Netherlands. Our mission is to stimulate and guide pharmaceutical companies to do more for the two billion people worldwide who cannot access the medicines they need. The core pillar of our work is researching how pharmaceutical companies address the affordability and accessibility of their products in low and middle-income countries. To turn our research into real-world change, we engage with leading organisations, including companies, NGOs and governments.

Role and responsibilities

We are looking for a researcher that will join the Access to Medicine Index team to strengthen the research capacities of the Foundation. 

Main responsibilities may include, but are not limited to: 

  • Have oversight and further develop specific technical areas within the methodology of the ATM Index, and other activities, where needed; 
  • Select and manage appropriate sources of information related to the Access to Medicine Foundation and its products; 
  • Critically analyse large amounts of qualitative and quantitative data associated with one or more technical areas; 
  • Conduct a detailed evaluation of company performance, with the ability to generate specific, defensible and actionable recommendations for companies and to present these to companies; 
  • Prepare documents and discussion papers for the research team to discuss and present the methodology to experts, external stakeholders and reviewers; 
  • Upon request, present the Access to Medicine Foundation Index research activities at conferences and external events, including educational seminars; 
  • Develop and manage key stakeholder relationships as relevant to the position; 
  • Actively contribute ideas to improve the products of the Access to Medicine Foundation going forward; 
  • Active involvement in designing and writing the main Access to Medicine Foundation’s publications and tools; 
  • Collaborate efficiently with other staff members, including those in charge of producing the AMR Benchmark, coordinating the operations of the Foundation and leading the engagement with companies.

The researcher will report directly to the Access to Medicine Index Research Programme Manager. 

Profile and essential skills

  • A graduate degree (Masters/MD or PhD level) in health related disciplines (e.g., business, finance, (health) economics, life sciences, epidemiology, pharmaceutical sciences, global health, or equivalent); 
  • At least three years of professional working experience in the field of medicine/global health in low- and middle-income countries; 
  • Strong research and analytical skills to interpret and analyse large amounts of data, accurately and thoroughly while keeping to deadlines; 
  • Expert use of Excel, Google sheets and statistical packages and proven experience in effective internet searches (i.e. google alerts) for market intelligence; 
  • Excellent communication skills (writing/speaking) in English; 
  • Speak and engage confidently with a challenging set of stakeholders on various issues related to access to medicine, including affordability, patents, among others; 
  • Strong understanding of and experience in working with different pricing regimes; 
  • Having published peer-reviewed academic papers in at least one of the key areas of access to medicine (e.g. Research & Development, Pricing, Patents, Policy, Supply, Capacity building); 
  • Experience in at least one of the key areas of pharmaceutical industry activity in access to medicine is a plus (e.g., topics like pricing, product development, governance, IP management). 


The Access to Medicine Foundation offers benefits that include 25 days’ annual leave (pro rata), company pension scheme, holiday allowance and reimbursement of public transport to work (if living beyond 10KM from the office). 

More about the Access to Medicine Foundation

Our research products, The Access to Medicine Index and the Antimicrobial Resistance Benchmark, are valued by a wide network of experts and external stakeholders including pharmaceutical companies and industry watchers, governments, international agencies such as the United Nations and World Health Organization, pharma journalists, investors and global health professionals and academics. The Foundation also publishes stand-alone studies about the pharmaceutical industry. It identifies best practices, highlights where progress is being made, and uncovers where critical action is still required. 

With these tools and outreach work, the Foundation provides both an incentive and a guide for pharmaceutical companies to do more to improve access to medicine. Each new product brings new opportunities to stimulate change and to advance the global debate on access to medicine. Quality research and analysis are essential activities within the Access to Medicine Foundation to achieve these change-making goals. 

Get a sense of how our work is used in the media and across the global health community

How to apply

Interested candidates should send a motivation letter, CV, two references, and one writing sample (i.e. published article, thesis or white paper) to Mrs Mireille Deen at mdeen@accesstomedicinefoundation.org

The application will not be considered unless it is complete and all supporting documentation has been provided. There will be no compensation for relocation costs.

Got a question?

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.